The efficiency and safety of low ‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer

ConclusionLow-dose apatinib combined with oral vinorelbine demonstrates potential efficacy and well tolerated for pretreated HER2-negative mBC.

Source: Cancer Medicine - April 25, 2024 Category: Cancer & Oncology Authors: Jia ‐Yi Huang, Xue‐Lian Chen, Xiao‐Feng Xie, Lin Song, Li‐Ping Chen, Xiao‐Feng Lan, Xue Bai, Xiao Chen, Cai‐Wen Du Tags: RESEARCH ARTICLE Source Type: research